T0	Participants 49 63	schizophrenia:
T1	Participants 225 241	in schizophrenia
T2	Participants 738 839	in schizophrenia patients with negative symptoms who were receiving second generation antipsychotics.
T3	Participants 840 860	Forty-three subjects